AI Article Synopsis
- Human lipodystrophies, like Barraquer-Simons syndrome, are rare and often go undiagnosed, leading to potential health and psychological issues.
- This syndrome results in the loss of subcutaneous fat mainly in the upper body without severe metabolic complications, but patients may exhibit low complement-component 3 levels.
- The case of a 31-year-old woman exemplifies these features, underscoring the need for awareness and management of this condition to mitigate its consequences.
Article Abstract
Background: Human lipodystrophies are uncommon disorders, with important clinical consequences, which are often undiagnosed. The Barraquer-Simons syndrome is a form of partial symmetric lipodystrophy of unknown etiology, characterized by the loss of subcutaneous adipose tissue, limited to upper part of the body. Insulin resistance and metabolic complications are less common than with other lipodystrophy subtypes. Patients usually have decreased serum complement-component 3 levels, associated with complement activation by the alternative pathway, which may indicate the presence of renal involvement.
Case Presentation: The authors report a case of a 31-year-old woman with progressive loss of subcutaneous fat, limited to the face, neck and thorax. She presented no severe metabolic complications, neither signs of insulin resistance. Laboratory tests revealed mild dyslipidemia, and low serum levels of complement-component 3. Clinical and biochemical characteristics were consistent with the diagnosis of Barraquer-Simons syndrome.
Conclusion: The present case illustrates the importance of recognizing the clinical features of this lipodystrophic syndrome, which may present potentially severe consequences and psychological distress. A brief overview is made, addressing the clinical signs of the disease, its course, and how to manage it.
Download full-text PDF |
Source |
|---|---|
| http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4797229 | PMC |
| http://dx.doi.org/10.1186/s13104-016-1975-9 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Barraquer-Simons Syndrome Associated with Myopathy - A Rare Entity.
Indian Dermatol Online J
November 2023
Department of Dermatology and Venereology, Government Medical College Trivandrum, Kerala, India.
Partial lipodystrophy: Clinical presentation and treatment.
Ann Endocrinol (Paris)
June 2024
Inserm U938, Centre de recherche Saint-Antoine, Institut de cardiométabolisme et nutrition (ICAN), Sorbonne université, Paris, France; Service d'endocrinologie, hôpital Saint-Antoine, Centre de référence des maladies rares de l'insulino-sécrétion et de l'insulino-sensibilité (PRISIS), Assistance publique-Hôpitaux de Paris (AP-HP), Paris, France.
Article Synopsis
- - Lipodystrophic syndromes are rare diseases, either acquired or genetic, that cause a significant lack of fat tissue, leading to severe metabolic issues like insulin resistance and high triglycerides.
- - These syndromes can be underdiagnosed, especially in partial forms, where individuals may still have some fat but experience additional problems due to excess fat in certain body areas.
- - Diagnosis involves clinical evaluations and metabolic tests, and early lifestyle changes alongside tailored medical support are crucial; in some cases, the medication metreleptin may be prescribed if other treatments fail.
Gestational and neonatal outcomes of women with partial Dunnigan lipodystrophy.
Front Endocrinol (Lausanne)
April 2024
Brazilian Group for the Study of Inherited and Acquired Lipodystrophies (BRAZLIPO), Fortaleza, Brazil.
Article Synopsis
- Lipodystrophies are disorders that cause the selective loss of fat tissue, leading to increased risks of insulin resistance and related health issues, particularly in women with familial partial lipodystrophy type 2 (FPLD2), who also often face complications with pregnancy and gynecological conditions like PCOS.
- The study conducted a retrospective analysis of 8 women diagnosed with FPLD2 who had pregnancies, examining their pregnancy outcomes and associated complications.
- Results indicated significant fetal complications, including high rates of gestational diabetes, preeclampsia, miscarriages, and other neonatal issues, although no cases of infertility were reported.
Eponyms that honor Jewish dermatologists: A celebration and a remembrance, Part three: Jewish physicians who practiced during the Holocaust and in its aftermath.
Clin Dermatol
June 2024
Department of Dermatology and Cutaneous Biology, Sidney Kimmel Medical College at Thomas Jefferson University, Philadelphia, Pennsylvania, USA.
Part III of this contribution continues to celebrate the many contributions that Jewish physicians have made to advance the specialty of dermatology, as reflected by eponyms that honor their names. Part I covered the years before 1933, a highly productive period of creativity by Jewish dermatologists, especially in Germany and Austria. The lives of 17 Jewish physicians and their eponyms were described in Part I.
View Article and Find Full Text PDFWant AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!